Bile Acid Sequestrants Market Share

North American Market Statistics

The bile acid sequestrants market in the North American region to hold the highest position in the coming years due to bile acid sequestrants' high usage to treat pruritus in liver cirrhosis patients. For instance, multiple case series and randomized controlled trials (RCTs) discovered that cholestyramine is effective in substantially limiting pruritus symptoms and serum bile acids, with 75% of patients in North America reporting indication relief. cholestyramine is used for the treatment of pruritus for its activity in reducing the “pruritogens” that gather in cholestatic forms of liver disease.

European Market Analysis

The bile acid sequestrants market is expected to extend substantially in Europe throughout the anticipated time frame. Some factors affecting the market growth involve the increasing prevalence of type 2 diabetes in the area. Diabetes is more common among older people: 19.3 million people 60-79 years old have diabetes across EU countries, in comparison with 11.3 million people 40-59 years old and only 1.7 million 20-39 years old. While more men than women have diabetes in middle age (between 40 and 59 years old), a higher number of women have diabetes after age 70 primarily because they live longer. Also, the region is experiencing a demand for potent drug treatments because of the region's substantial patient base of people with cardiovascular disorders, particularly hyperlipidemia. For market players in the region, technological developments in drug delivery methods and the creation of novel medications should present profitable growth prospects.